Low efficacy of recombinant SV40 in Ugt1a1(-/-) mice with severe inherited hyperbilirubinemia

In contrast to AAV, Simian Virus 40 (rSV40) not inducing neutralizing antibodies (NAbs) allowing re-treatment seems a promising vector for neonatal treatment of inherited liver disorders. Several studies have reported efficacy of rSV40 in animal models for inherited liver diseases. In all studies th...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Xiaoxia, Bortolussi, Giulia, Bloemendaal, Lysbeth ten, Duijst, Suzanne, Muro, Andrés F., Bosma, Piter J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064607/
https://www.ncbi.nlm.nih.gov/pubmed/33891666
http://dx.doi.org/10.1371/journal.pone.0250605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064607/
https://www.ncbi.nlm.nih.gov/pubmed/33891666
http://dx.doi.org/10.1371/journal.pone.0250605

Ejemplares similares